Research reports

Zenicor Medical Systems AB was founded in 2003 and has since then been established as one of the lead players in the fields of early diagnosis of arrhythmias and stroke prevention.

A large number of research studies spanning from pediatric cardiology to early diagnosis of arrhythmias, cost-effectiveness and Data-driven screening have been performed since the start. These studies have established good diagnositc abitlity, in many cases clearly superior to conventional methods, and excellenat results in terms of health economics. In addition to this, the research results have led to new, more efficient work methods for the healthcare.

An effective method to prevent stroke using the Zenicor Solution for primary preventive atrial fibrillation screening has been developed and tested. The screening research has attracted a great deal of attention globally and has led the way for atrial fibrillation screening. New ways to make screening more effective and cost-effective are still being explored together with top-researchers in the field.

Additionally a new and effective carepathway for patients presenting with symptoms of arrhythmias in primary care has been developed. A new workflow that digitalises the care pathway and makes care more accessible for the patient, which facilitates a quicker diagnosis. Research with the Zenicor Solution has been conducted at universities and hospitals in Sweden, Denmark, Norway, Switzerland, Austria, Germany and the UK.  This broschure (link below)  is a compilation of published research where the Zenicor Solution has been used and evaluated. A complete list of published research is found at the end of the broschure.

Clinical research folder with The Zenicor Solution